Next-generation sequencing
Next-generation sequencing

Unlock the potential of next-generation sequencing

Impactful discoveries powered by NGS

Next-generation sequencing (NGS) can deliver unprecedented insights, unraveling the intricacies of the genome and transcriptome in biomarker research, gene expression studies, viral epidemiology and disease surveillance, as well as comprehensive genomic profiling to identify variants implicated in cancer and other diseases. However, challenges such as workflow optimization, customization and data analysis and interpretation can hinder progress. Partner with QIAGEN to unlock the full potential of NGS with innovative QIAseq technologies.

Houston lab

Enhance your core facility offering

Learn how our partnership with leading service centers and core labs overcome typical lab bottlenecks and advance your research.
two scientist in front of a monitor
Automate and accelerate your library prep
Automating your NGS means more consistency between runs, less batch processing errors, fewer re-runs, plus significant time and cost savings.
Uncover more biology with NGS technology

Navigate the complexity of the NGS world with ease by partnering with QIAGEN. Benefit from extensive expertise, tailored solutions and market-leading informatics so you can achieve:

  • Accurate results from even the most challenging of samples
  • Faster turnaround times using streamlined and optimized workflows
  • Meaningful insights from complex NGS data
From challenging samples to integrated insights

Got challenging samples? Don’t write them off yet! With QIAseq, you can access the most difficult regions of the genome and derive impactful insights from the toughest of samples.

  • FFPE and liquid biopsy samples
  • Limited DNA and RNA samples
  • GC-rich regions
  • Low-frequency variants
  • Exonic regions
Did you know?
QIAseq NGS products have been featured in >3000 publications in just the past four years.
High-throughput genomic surveillance of emerging SARS-CoV-2 Delta, Mu and Omicron variants

The emergence of new, highly transmissible SARS-CoV-2 variants has elevated the need for high-throughput whole viral genome sequencing to accelerate genomic surveillance efforts. Cataloging new variants and evaluating the impact of the accumulated mutations is critical for vaccine development and effective public health measures. Explore how our high-performance, scalable NGS workflows with integrated bioinformatics facilitate accurate SARS-CoV-2 variant detection and phylogeographic tracking.

Corona virus
Go from RNA-seq to gene expression insights with ease

Struggling to make sense of your RNA-seq data? Take the stress out of data analysis and fast-track your path to gene expression insights with the new RNA-seq Analysis Portal. Designed for biologists and fully integrated with GeneGlobe, this intuitive, web-based solution is now included with QIAseq RNA-seq and miRNA-seq kits. Simply upload your sequence files into the RNA-seq Analysis Portal, start your analysis and go from FASTQ files to focused insights into the top 10 canonical pathways, upstream regulators and diseases using powerful IPA knowledge bases.

Expanding disease insights with exome sequencing

The coding portion of the genome holds tantalizing information on multiple diseases. Unlocking these details through exome sequencing can reveal powerful insights into disease-associated variants. However, coverage issues, long turnaround times and data analysis bottlenecks can diminish progress. Explore a time-saving workflow that seamlessly combines uniform exome coverage with streamlined secondary analysis, rapid variant filtering and annotation.

Explore benefits of QIAseq NGS
Get in touch to see how QIAseq NGS solutions can transform your research.
woman infront of a touchscreen
Accelerate integrated insights from NGS data with maximum ease
You’ve run your benchtop experiment and finally achieved NGS data. But what does it all mean? Demystify data analysis and interpretation with our intuitive bioinformatics tools.
QIAseq Targeted cfDNA Ultra Panels
QIAseq Targeted cfDNA Ultra Panels
Detect ultra-rare variants in cfDNA at 0.1% VAF and go from sample to NGS-ready libraries in just 8 hours using our panels.
Discover the panels
QIAseq xHYB Human Hybrid Capture Panels
QIAseq xHYB Human Hybrid Capture Panels
Hybrid capture-based enrichment for comprehensive variant detection with minimal sequencing effort.
Learn how
Stay up-to-date on all latest developments in NGS!
Sign up for the QIAGENomics newsletter and get updates sent to your inbox every month.

Useful resources to fuel your research

Science Matters blog
Science Matters blog
Stay up-to-date on the latest developments in the world of genomics. Check out interesting articles, researcher interviews and more in our exciting blog.
Read the blog
On-demand webinars
On-demand webinars
Access our extensive range of on-demand webinars for useful tips and tricks, advice on overcoming typical workflow challenges and more.
View webinars
Key publications
Key publications
Discover the impact of QIAseq NGS solutions in diverse research applications by browsing through our compilation of publication highlights.
View citations
Woman in lab smiling

Meet the recipients of the 2021 QIAGEN RNA-seq Grant

In 2021, we invited researchers to explore the potential of RNA-seq for their research by applying for a QIAGEN RNA-seq Grant. We received an astounding 2400 applications and are pleased to announce the grant recipients.
All photos taken prior to COVID-19